de Haan, Aalzen <br/><br/>
Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.  [electronic resource] 

 -  Vaccine  Jul 2012 
 - 4884-91 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2012.04.032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Administration, Intranasal<br/>Animals<br/>Antibodies, Viral--blood<br/>Antibody Formation<br/>Antibody Specificity<br/>Antigens, Viral--immunology<br/>Cross Protection<br/>Hemagglutination Inhibition Tests<br/>Immunity, Mucosal<br/>Immunoglobulin G--blood<br/>Influenza A Virus, H1N1 Subtype<br/>Influenza Vaccines--administration & dosage<br/>Lactococcus lactis--immunology<br/>Lung--virology<br/>Mice<br/>Mice, Inbred BALB C<br/>Orthomyxoviridae Infections--immunology<br/>Vaccines, Inactivated--administration & dosage